Cargando…

Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important potential for disease modelling and regeneration. Whether the hPSC-KCs can reconstitute tissue-specific phenotypes is currently unknown. Here we show that hPSC-KCs self-organize into kidney organoids that functionally recapit...

Descripción completa

Detalles Bibliográficos
Autores principales: Freedman, Benjamin S., Brooks, Craig R., Lam, Albert Q., Fu, Hongxia, Morizane, Ryuji, Agrawal, Vishesh, Saad, Abdelaziz F., Li, Michelle K., Hughes, Michael R., Werff, Ryan Vander, Peters, Derek T., Lu, Junjie, Baccei, Anna, Siedlecki, Andrew M., Valerius, M. Todd, Musunuru, Kiran, McNagny, Kelly M., Steinman, Theodore I., Zhou, Jing, Lerou, Paul H., Bonventre, Joseph V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620584/
https://www.ncbi.nlm.nih.gov/pubmed/26493500
http://dx.doi.org/10.1038/ncomms9715
_version_ 1782397320106606592
author Freedman, Benjamin S.
Brooks, Craig R.
Lam, Albert Q.
Fu, Hongxia
Morizane, Ryuji
Agrawal, Vishesh
Saad, Abdelaziz F.
Li, Michelle K.
Hughes, Michael R.
Werff, Ryan Vander
Peters, Derek T.
Lu, Junjie
Baccei, Anna
Siedlecki, Andrew M.
Valerius, M. Todd
Musunuru, Kiran
McNagny, Kelly M.
Steinman, Theodore I.
Zhou, Jing
Lerou, Paul H.
Bonventre, Joseph V.
author_facet Freedman, Benjamin S.
Brooks, Craig R.
Lam, Albert Q.
Fu, Hongxia
Morizane, Ryuji
Agrawal, Vishesh
Saad, Abdelaziz F.
Li, Michelle K.
Hughes, Michael R.
Werff, Ryan Vander
Peters, Derek T.
Lu, Junjie
Baccei, Anna
Siedlecki, Andrew M.
Valerius, M. Todd
Musunuru, Kiran
McNagny, Kelly M.
Steinman, Theodore I.
Zhou, Jing
Lerou, Paul H.
Bonventre, Joseph V.
author_sort Freedman, Benjamin S.
collection PubMed
description Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important potential for disease modelling and regeneration. Whether the hPSC-KCs can reconstitute tissue-specific phenotypes is currently unknown. Here we show that hPSC-KCs self-organize into kidney organoids that functionally recapitulate tissue-specific epithelial physiology, including disease phenotypes after genome editing. In three-dimensional cultures, epiblast-stage hPSCs form spheroids surrounding hollow, amniotic-like cavities. GSK3β inhibition differentiates spheroids into segmented, nephron-like kidney organoids containing cell populations with characteristics of proximal tubules, podocytes and endothelium. Tubules accumulate dextran and methotrexate transport cargoes, and express kidney injury molecule-1 after nephrotoxic chemical injury. CRISPR/Cas9 knockout of podocalyxin causes junctional organization defects in podocyte-like cells. Knockout of the polycystic kidney disease genes PKD1 or PKD2 induces cyst formation from kidney tubules. All of these functional phenotypes are distinct from effects in epiblast spheroids, indicating that they are tissue specific. Our findings establish a reproducible, versatile three-dimensional framework for human epithelial disease modelling and regenerative medicine applications.
format Online
Article
Text
id pubmed-4620584
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-46205842015-12-08 Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids Freedman, Benjamin S. Brooks, Craig R. Lam, Albert Q. Fu, Hongxia Morizane, Ryuji Agrawal, Vishesh Saad, Abdelaziz F. Li, Michelle K. Hughes, Michael R. Werff, Ryan Vander Peters, Derek T. Lu, Junjie Baccei, Anna Siedlecki, Andrew M. Valerius, M. Todd Musunuru, Kiran McNagny, Kelly M. Steinman, Theodore I. Zhou, Jing Lerou, Paul H. Bonventre, Joseph V. Nat Commun Article Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important potential for disease modelling and regeneration. Whether the hPSC-KCs can reconstitute tissue-specific phenotypes is currently unknown. Here we show that hPSC-KCs self-organize into kidney organoids that functionally recapitulate tissue-specific epithelial physiology, including disease phenotypes after genome editing. In three-dimensional cultures, epiblast-stage hPSCs form spheroids surrounding hollow, amniotic-like cavities. GSK3β inhibition differentiates spheroids into segmented, nephron-like kidney organoids containing cell populations with characteristics of proximal tubules, podocytes and endothelium. Tubules accumulate dextran and methotrexate transport cargoes, and express kidney injury molecule-1 after nephrotoxic chemical injury. CRISPR/Cas9 knockout of podocalyxin causes junctional organization defects in podocyte-like cells. Knockout of the polycystic kidney disease genes PKD1 or PKD2 induces cyst formation from kidney tubules. All of these functional phenotypes are distinct from effects in epiblast spheroids, indicating that they are tissue specific. Our findings establish a reproducible, versatile three-dimensional framework for human epithelial disease modelling and regenerative medicine applications. Nature Pub. Group 2015-10-23 /pmc/articles/PMC4620584/ /pubmed/26493500 http://dx.doi.org/10.1038/ncomms9715 Text en Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Freedman, Benjamin S.
Brooks, Craig R.
Lam, Albert Q.
Fu, Hongxia
Morizane, Ryuji
Agrawal, Vishesh
Saad, Abdelaziz F.
Li, Michelle K.
Hughes, Michael R.
Werff, Ryan Vander
Peters, Derek T.
Lu, Junjie
Baccei, Anna
Siedlecki, Andrew M.
Valerius, M. Todd
Musunuru, Kiran
McNagny, Kelly M.
Steinman, Theodore I.
Zhou, Jing
Lerou, Paul H.
Bonventre, Joseph V.
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
title Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
title_full Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
title_fullStr Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
title_full_unstemmed Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
title_short Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
title_sort modelling kidney disease with crispr-mutant kidney organoids derived from human pluripotent epiblast spheroids
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620584/
https://www.ncbi.nlm.nih.gov/pubmed/26493500
http://dx.doi.org/10.1038/ncomms9715
work_keys_str_mv AT freedmanbenjamins modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT brookscraigr modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT lamalbertq modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT fuhongxia modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT morizaneryuji modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT agrawalvishesh modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT saadabdelazizf modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT limichellek modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT hughesmichaelr modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT werffryanvander modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT petersderekt modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT lujunjie modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT bacceianna modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT siedleckiandrewm modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT valeriusmtodd modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT musunurukiran modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT mcnagnykellym modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT steinmantheodorei modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT zhoujing modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT leroupaulh modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids
AT bonventrejosephv modellingkidneydiseasewithcrisprmutantkidneyorganoidsderivedfromhumanpluripotentepiblastspheroids